NCT06689605 Ultrasound-guided Tru-cut Biopsy in Patients with Suspected Ovarian Cancer: Adequacy, Accuracy, Safety and Patient Assessment.
| NCT ID | NCT06689605 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Hradec Kralove |
| Condition | Ovarian Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-01-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective observational study is to evaluate the role of ultrasound-guided tru-cut biopsy (in the hands of an expert certified sonographer within a gynecological center)in patients with suspected ovarian cancer. The main questions it aims to answer are: Is the material from tru-cut biopsy adequate for histopathological and immunohistochemical examination? Is the material accurate in comparison with the final pathological specimen? What are the patient experience and complications after the procedure? Participants who will undergo a standard tru-cut biopsy procedure will need to additionally answer the questionnaire.
Eligibility Criteria
Inclusion Criteria: * suspected advanced ovarian cancer * indication for tru-cut biopsy by multidisciplinary oncoboard Exclusion Criteria: * patient deny to undergo tru-cut biopsy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06689605 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Ovarian Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06689605 currently recruiting?
Yes, NCT06689605 is actively recruiting participants. Contact the research team at munachiso.ndukwe@fnhk.cz for enrollment information.
Where is the NCT06689605 trial being conducted?
This trial is being conducted at Hradec Králové, Czechia.
Who is sponsoring the NCT06689605 clinical trial?
NCT06689605 is sponsored by University Hospital Hradec Kralove. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.